Elicio Therapeutics
(NASDAQ) ELTX
Elicio Therapeutics Financials at a Glance
Market Cap
$192.06M
Revenue (TTM)
$0.00
Net Income (TTM)
$39.57M
EPS (TTM)
$-2.56
P/E Ratio
-4.08
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$10.38
Volume
3,048
Open
$11.00
Price
$10.38
Volume
3,048
Open
$11.00
Previous Close
$10.38
Daily Range
$10.33 - $11.00
52-Week Range
$4.60 - $14.93
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$10.38
Volume
3,048
Open
$11.00
Previous Close
$10.38
Daily Range
$10.33 - $11.00
52-Week Range
$4.60 - $14.93
ELTX News
ELTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Elicio Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
33
CEO
Robert T. Connelly
Website
www.elicio.comHeadquarters
Boston, MA 02210, US
ELTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-60013%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-24.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$192.06M
Shares Outstanding
18.40M
Volume
3.05K
Short Interest
0.00%
Avg. Volume
130.87K
Financials (TTM)
Gross Profit
$1.13M
Operating Income
$37.71M
EBITDA
$36.59M
Operating Cash Flow
$36.95M
Capital Expenditure
$16.00K
Free Cash Flow
$36.97M
Cash & ST Invst.
$18.56M
Total Debt
$14.51M
Elicio Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$286.00K
+6.2%
Gross Margin
0.00%
N/A
Market Cap
$192.06M
N/A
Market Cap/Employee
$6.00M
N/A
Employees
32
N/A
Net Income
$7.72M
+44.9%
EBITDA
$6.37M
+52.7%
Quarterly Fundamentals
Net Cash
$13.46M
+259.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$4.09M
-83.7%
Short Term Debt
$1.01M
+12.2%
Return on Assets
-1.53%
N/A
Return on Invested Capital
-2.12%
N/A
Free Cash Flow
$6.81M
+22.5%
Operating Cash Flow
$6.80M
+22.3%